Tumour-Secreted Protein S (ProS1) Activates a Tyro3-Erk Signalling Axis and Protects Cancer Cells from Apoptosis
The TAM subfamily (Tyro3, Axl, MerTK) of receptor tyrosine kinases are implicated in several cancers, where they have been shown to support primary tumorigenesis as well as secondary resistance to cancer therapies. Relatively little is known about the oncogenic role of Tyro3, including its ligand se...
Main Authors: | Nour Al Kafri, Sassan Hafizi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-11-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/12/1843 |
Similar Items
-
Identification of signalling pathways activated by Tyro3 that promote cell survival, proliferation and invasiveness in human cancer cells
by: Nour Al Kafri, et al.
Published: (2021-12-01) -
Galectin-3 Stimulates Tyro3 Receptor Tyrosine Kinase and Erk Signalling, Cell Survival and Migration in Human Cancer Cells
by: Nour Al Kafri, et al.
Published: (2020-07-01) -
TYRO3 promotes chemoresistance via increased LC3 expression in pancreatic cancer
by: Kazushi Hara, et al.
Published: (2023-02-01) -
Tyro3 Targeting as a Radiosensitizing Strategy in Bladder Cancer through Cell Cycle Dysregulation
by: Linda Silina, et al.
Published: (2022-08-01) -
The first laminin G-like domain of protein S is essential for binding and activation of Tyro3 receptor and intracellular signalling
by: Nour Al Kafri, et al.
Published: (2022-07-01)